The Ohio Bioscience Report
The Ohio Bioscience Report is published by BioOhio, the state’s bioscience organization, to inform the public on the progress of Ohio’s bioscience industry, research endeavors, and community at large.
The following are key findings from the full 2019 Ohio Bioscience Report, which you can download below.
The report presents factual findings analyzing the bioscience sector within the state and its six geographic regions. To present content relevant to the full continuum of bioscience in Ohio, information is provided on the six core bioscience subsectors as well as critical contributors to the industry. All of these sectors have a common goal, to improve the quality of life for our community. Click here to learn more about these fields.
- Agricultural Biotechnology
- Medical & Testing Labs
- Medical Devices & Equipment
- Medical Product Distribution
- Pharmaceuticals & Therapeutics
- Research & Development
- Bioscience Education Institutions
- Contract Manufacturers & Suppliers
- Health and Medical Insurance Carriers
- Health IT Companies
- Healthcare Providers
- Professional Service Providers
Ohio’s bioscience industry continues its strong history of innovation and discovery, with at least 3,300 organizations manufacturing products, providing essential services, or researching the next breakthrough at nearly 4,100 facilities around the state.
The bioscience industry’s economic impact is felt throughout the state, with bioscience-related companies found in 83 of 88 Ohio counties. All six Ohio regions have experienced growth in the bioscience industry and play a role in advancing critical discoveries.
Bioscience firms employ over 75,000 people in Ohio at companies ranging from the large and well known such as Abbott, Battelle, Cardinal Health, Ethicon (a Johnson & Johnson company), Midmark, and STERIS, to young and growing companies including Abeona Therapeutics, Enable Injections, and ExonanoRNA.
Bioscience companies continue to expand operations and announce new facilities in the state, with 38 projects announced in 2018, projecting creation of 4,949 jobs and over $492 million in capital investment. AxoGen, CoverMyMeds, Eccrine Systems, Hardy Diagnostics, Inogen, Medline, North Coast Natural Solutions, Rhinosystems, Sarepta Therapeutics, ScriptDrop, Stirling Ultracold, and WDSrx are all among the many companies growing in Ohio
Ohio Counties Home to a Bio Company
Private Investment (2018)
Private Investment (2019 Preliminary 8/19)
Ohio bioscience companies attracted over $4.3 billion in funding in 2018, from sources including venture capital, exits, angel investment, federal research grants, and state initiatives.
BioOhio analysis indicates that over 120 Ohio bioscience-related companies announced $672 million in private investment in 2018, the highest level recorded since BioOhio began tracking deals in 2004.
Exit activity in the state remained strong in 2018, totaling over $2.7 billion, including significant public offerings from AtriCure and ViewRay.
Bioscience education continues to thrive in Ohio. In 2017, 11,403 bioscience-related degrees and certificates were awarded to students in Ohio, an increase of 69% since 2006. The number of schools with bioscience-related programs has also increased, from 79 in 2006 to over 90 public and private schools furthering the capabilities of Ohio’s talented workforce in 2017.